At 11:15 am on Aug. 17, the Health Resources & Services Administration released an advanced copy of a Federal Register notice proposing another delay in its final rule on calculating 340B drug prices (and imposing civil money penalties for manufacturers who violate those rules).
By noon, shares of Horizon Pharma PLC were up